COO Cooper Companies Inc.

CooperCompanies Announces Release Date for First Quarter 2021

CooperCompanies Announces Release Date for First Quarter 2021

SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.   Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at and a transcript of the call will be archived on this site for a minimum of 12 months.  

A recording of the call will be available beginning at 8:00 PM ET on March 4, 2021 through March 11, 2021. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 266737.

About CooperCompanies

CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit .

Contact:

Kim Duncan

Vice President, Investor Relations and Risk Management

925-460-3663



EN
04/02/2021

Underlying

COOCooper Companies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cooper Companies Inc.

 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces First Quarter 2024 Results

CooperCompanies Announces First Quarter 2024 Results SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.85, up $0.12 or 18% from last year's firs...

February 29, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies 4-for-1 Stock Split Effective Friday (2/16)

CooperCompanies 4-for-1 Stock Split Effective Friday (2/16) SAN RAMON, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced that its four-for-one stock split will become effective on Friday, February 16, 2024, at 5:00 PM ET, and trading is expected to begin on a stock split-adjusted basis at market open on Tuesday, February 20, 2024, under the existing trading symbol “COO”. The stock split supports Cooper’s desire to make ownership of its stock more accessible to employees and investors. Cooper previously announced on its fourth quarter 2023 earnings re...

February 15, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Release Date for First Quarter 2024

CooperCompanies Announces Release Date for First Quarter 2024 SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5337119. A simultaneous audio webcast and subsequent replay can be accessed at . About CooperCompaniesCooperCompanies (N...

January 25, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

CooperCompanies to Present at the J.P. Morgan Healthcare Conference SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . A replay of the event will be available on the same webpage following its conclusion. About...

December 21, 2023 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Sets Annual Meeting And Stockholder Record Dates

CooperCompanies Sets Annual Meeting And Stockholder Record Dates SAN RAMON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Cooper Companies (Nasdaq: COO) announced today that it will hold its next annual meeting of stockholders on Tuesday, March 19, 2024. Stockholders of record as of the close of business on January 24, 2024, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors. About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The...

December 19, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch